Type | Investment In | Percentage of NAV | No. of shares | Value(Rs in cr) |
Domestic Equities | HFCL Limited | 8.2869 | 2390000 | 35.7592 |
Domestic Equities | Pfizer Ltd | 8.0601 | 57346 | 34.7806 |
Domestic Equities | Aurobindo Pharma Limited | 7.9031 | 217300 | 34.1031 |
Domestic Equities | Dr. Reddy's Laboratories Limited | 7.1940 | 44150 | 31.0434 |
Domestic Equities | Zydus Wellness Ltd | 6.8268 | 128346 | 29.4586 |
Domestic Equities | Glaxosmithkline Pharmaceuticals Ltd | 6.4251 | 101000 | 27.7255 |
Domestic Equities | Aster DM Healthcare Limited | 5.7508 | 610164 | 24.8154 |
Domestic Equities | IPCA Laboratories Ltd | 5.4871 | 171000 | 23.6775 |
Domestic Equities | SMS Pharmaceuticals Limited | 5.1960 | 661886 | 22.4214 |
Domestic Equities | Zydus Lifesciences Limited | 5.0969 | 195000 | 21.9941 |
Domestic Equities | Glenmark Life Sciences Limited | 4.5129 | 185000 | 19.4740 |
Domestic Equities | Aarti Pharmalabs Limited | 4.4814 | 280852 | 19.3381 |
Domestic Equities | Sequent Scientific Limited | 4.3189 | 1138968 | 18.6369 |
Domestic Equities | Divi's Laboratories Limited | 3.4116 | 28900 | 14.7214 |
Domestic Equities | Suven Life Sciences Ltd. | 2.7440 | 830000 | 11.8408 |
Domestic Equities | RPG Life Sciences Limited | 1.8839 | 38610 | 8.1295 |
Domestic Equities | Sanofi Consumer Healthcare India Limited | 0.6907 | 7900 | 2.9804 |
Total | | 88.2703 | | 380.8999 |
Cash & Cash Equivalents and Net Assets | TREPS 02-Sep-2024 DEPO 10 | 11.4826 | 49567 | 49.5492 |
Cash & Cash Equivalents and Net Assets | NCA-NET CURRENT ASSETS | -4.5082 | | -19.4537 |
Total | | 6.9744 | | 30.0955 |
Derivatives-Futures | Divi's Laboratories Limited 26/09/2024 | 4.7554 | 40000 | 20.5202 |
Total | | 4.7554 | | 20.5202 |